Detalles de la búsqueda
1.
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).
Mod Rheumatol
; 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38491996
2.
Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).
J Orthop Sci
; 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37076376
3.
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics.
Mod Rheumatol
; 32(4): 718-727, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918129
4.
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study.
Mod Rheumatol
; 31(4): 796-802, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33492191
5.
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
Mod Rheumatol
; 30(3): 434-441, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31390271
6.
Disease activity early in treatment as a predictor of future low disease activity in RA patients treated with iguratimod.
Mod Rheumatol
; 26(2): 169-74, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26140467
7.
Inhibition of hyaluronan synthesis alters sulfated glycosaminoglycans deposition during chondrogenic differentiation in ATDC5 cells.
Histochem Cell Biol
; 144(2): 167-77, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25929745
8.
Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.
Rheumatology (Oxford)
; 54(5): 854-9, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25339638
9.
Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
Rheumatol Int
; 35(10): 1707-16, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25991396
10.
Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts.
Arthritis Rheum
; 65(5): 1160-70, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23335273
11.
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients.
Mod Rheumatol
; 23(5): 904-12, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22975734
12.
Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.
Clin Rheumatol
; 40(8): 3143-3151, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34136969
13.
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry.
Sci Rep
; 10(1): 21907, 2020 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318522
14.
Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab.
Joint Bone Spine
; 87(6): 596-602, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32534200
15.
Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis.
Int J Rheum Dis
; 20(9): 1193-1200, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26544115
16.
Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages.
Arthritis Res Ther
; 18(1): 133, 2016 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27267914
17.
Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental rheumatoid arthritis.
Bone
; 83: 210-219, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26603475
18.
Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients.
Clin Rheumatol
; 35(1): 219-25, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26631102
19.
Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
Clin Rheumatol
; 35(4): 863-71, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26846135
20.
Concomitant Methotrexate Protects Against Total Knee Arthroplasty in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors.
J Rheumatol
; 42(12): 2255-60, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26428206